Korro Bio (KRRO) Interest Coverage Ratio (2018 - 2023)
Korro Bio's (KRRO) quarterly Interest Coverage Ratio came in at 70.73 in Q1 2023, up 45.87% on a YoY basis from 48.48 in Q1 2022, and down 479.93% quarter-over-quarter from 18.62 in Q4 2022.
Powered by 
Analysis
Korro Bio (KRRO) Interest Coverage Ratio (2018 - 2023) Analysis & Trends
Korro Bio (KRRO) has reported Interest Coverage Ratio for 4 consecutive years, with 70.73 the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Interest Coverage Ratio rose 45.87% year-over-year to 70.73; the trailing twelve-month figure through Sep 2023 stood at 86.97 (up 16.12% YoY), and the FY2022 full-year result was 61.39, up 44.18% from the prior year.
- Interest Coverage Ratio fell to 70.73 in Q1 2023 per KRRO's latest filing, from 18.62 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 18.62 in Q4 2022 and bottomed at 137.31 in Q3 2021.
- Historically, Interest Coverage Ratio has averaged 89.5 across 3 years, with a median of 96.06 in 2021.
- The widest YoY moves for Interest Coverage Ratio: up 115.86% in 2022, down 41.02% in 2022.
- Over 3 years, Interest Coverage Ratio stood at 117.36 in 2021, then jumped by 115.86% to 18.62 in 2022, then slumped by 479.93% to 70.73 in 2023.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 70.73, 18.62, and 77.09 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Korro Bio | 230.80 Mn | 115.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -70.73 |
| Dec 31, 2022 | 18.62 |
| Sep 30, 2022 | -77.09 |
| Jun 30, 2022 | -102.27 |
| Mar 31, 2022 | -130.66 |
| Dec 31, 2021 | -117.36 |
| Sep 30, 2021 | -137.31 |
| Jun 30, 2021 | -96.06 |
| Mar 31, 2021 | -92.66 |
| Sep 30, 2018 | -80.27 |